Lonza Group AG (LONN)

293.90
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    295.90/297.50
  • Day's Range:
    291.50 - 293.90

LONN Overview

Prev. Close
289.6
Day's Range
291.5-293.9
Revenue
6.22B
Open
293.9
52 wk Range
0-0
EPS
16.37
Volume
0
Market Cap
44.71B
Dividend (Yield)
1.75
(N/A)
Average Vol. (3m)
107
P/E Ratio
17.79
Beta
0.623
1-Year Change
0%
Shares Outstanding
74,281,626
Next Earnings Date
-
What is your sentiment on Lonza Group?
or
Market is currently closed. Voting is open during market hours.

Lonza Group AG Company Profile

Lonza Group AG Company Profile

  • Type:Equity
  • Market:Germany
  • ISIN:CH0013841017
  • WKN:928619

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.

Read More

Analyst Price Target

Average668.47 (+13.92% Upside)
High900.00
Low325.00
Price586.80
No. of Analysts15
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary
  • My best friend works for Lonza in Spain... It's an amazing company and works for top bio companies like Moderna, Bointech or Bayer among others....
    0
    • Lonza growing fast. Visp growing as well. now starting with the vaccine production. Solid company.
      0
      • 600 target price
        0
        • based on what ?
          0
      • lonza new CEO
        0
        • do we know the reason Mr. Singarella ?
          0
          • Forecast https://walletinvestor.com/stock-forecast/lzagf-stock-prediction
            0
        • Seems this will keep going up
          0